Shoreline Biosciences has poached the leader of Pfizer’s cancer vaccines unit, Robert Hollingsworth, Ph.D., to serve as chief scientific officer for the startup, which has recently beefed up its leadership, financing and partnerships. Hollingsworth was chief scientific officer and vice president of cancer vaccines and immunotherapies at the New York Big Pharma, where he helped bring […]

Cell-based therapies can be developed in various ways, but companies look for methods that are faster and more efficient. At Houston, TX-based FibroBiologics scientists turn fibroblasts into potentially therapeutic uses. Hamid Khoja, PhD, chief scientific officer at FibroBiologics, calls fibroblasts “one of the most abundant cells in the human body.” He adds, “They can differentiate […]

The therapy could be ready for human clinical trials later this year. Researchers used implantable “drug factories” the size of a pinhead to deliver continuous, high doses of interleukin-2, a natural compound that activates white blood cells to fight cancer. The drug-producing beads can be implanted with minimally invasive surgery. Each contains cells engineered to […]